Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
David Marrero, PhD talks about both about the distress associated with diabetes, and the over-diagnosis of depression in diabetics. Proper diagnosis is essential to effective treatment of these symptoms,…
Virginia Valentine, CNS, BC-ADM, CDE offers her insights on the GLP-1 receptor agonists in patient therapy. The therapy is particularly effective when implemented into a lifestyle with the…
Charles F. Shaefer Jr., MD, FACP, FCCP discusses the patterns of glucose abnormalities in Type 2 diabetes in two areas: control of fasting blood sugar, and post-meal glucose elevations.…
David M. Nathan, MD provides an update on the new outcome study that was presented at the 74th Scientific Sessions of the American Diabetes Association in San Francisco, California in…
Neil K. Warma, President & CEO, Opexa Therapeutics, explains Opexa’s goal to create the first personalized therapy for patients with multiple sclerosis. He discusses the ABILI-T Phase 2 Clinical…
Anthony Grimaldi, MA, CASAC, Senior Vice President, BHM Healthcare Solutions, explains that the key to the success of total cost of care design lies in cross departmental data and…
Anthony Grimaldi, MA, CASAC, Senior Vice President, BHM Healthcare Solutions, explains the changes to the way that providers must deliver healthcare. He describes 5 fundamental differences in healthcare…
Georgia H. Witkin, PhD, Assistant Clinical Professor, Mt. Sinai Medical Center, gives the Three F’s to preparing for In Vitro Fertilization (IVF). Finances: Consider all direct and indirect…
When a surgically replaced heart valve fails, many patients can be treated with medications or undergo another surgery to replace the damaged valve. High risk patients, including those…
Connor Landgraf, CEO, Eko Devices, introduces the Eko, which converts the analog stethoscope into a powerful digital tool. He explains 3 primary uses for the Eko: 1) Primary…
